The Precision QID Blood Glucose Test Strips are intended for in vitro diagnostic use (i.e., for external use only) for the quantitative measurement of glucose in fresh capillary whole blood. For home or professional use with the Precision QID Blood Glucose Sensor. Compatible with the MediSense 2 Card and Pen Blood Glucose Sensors, and the Companion 2 Card and Pen Blood Glucose Sensors. The product may also be used by healthcare professionals for quantitative measurement of glucose in venous or arterial whole blood, provided the sample is used within 15 minutes.
Device Story
Precision QID Blood Glucose Test Strip uses amperometric biosensor technology to measure glucose in whole blood. User inserts strip into sensor; applies blood drop to target area. Glucose oxidase catalyzes oxidation of glucose to gluconic acid; electrochemical mediator transfers electrons to electrode surface, generating current proportional to glucose concentration. Sensor displays reading after 20 seconds. Used by patients at home or healthcare professionals in clinical settings. Output provides quantitative glucose concentration to assist in diabetes management.
Clinical Evidence
Clinical study at university medical center (N=320 arterial samples) compared Precision QID system results against whole blood and plasma hexokinase reference methods. Results showed correlation coefficients (r) of 0.961 (vs arterial whole blood) and 0.967 (vs arterial plasma). Performance was comparable to predicate capillary blood data (r=0.984).
Technological Characteristics
Amperometric biosensor; glucose oxidase enzyme; electrochemical mediator; disposable test strip form factor; compatible with MediSense/Precision sensor systems.
Indications for Use
Indicated for quantitative measurement of glucose in fresh capillary, venous, or arterial whole blood. Intended for use by people with diabetes (home use) and healthcare professionals (professional use).
Regulatory Classification
Identification
A glucose test system is a device intended to measure glucose quantitatively in blood and other body fluids. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.
Special Controls
*Classification.* Class II (special controls). The device, when it is solely intended for use as a drink to test glucose tolerance, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
K963676 — PRECISION G BLOOD GLUCOSE TESTING SYSTEM · Medisense, Inc. · Feb 20, 1997
K971812 — PRECISION QID BLOOD GLUCOSE TEST STRIP, PRECISION G BLOOD GLUCOSE TEST STRIP · Medisense, Inc. · Aug 8, 1997
K062829 — DIACHEX BLOOD GLUCOSE MONITORING SYSTEM · Tyson Bioresearch, Inc. · Oct 10, 2006
K070984 — THE PRECISION / OPTIUM POINT OF CARE BLOOD GLUCOSE TEST STRIPS · Abbott Diabetes Care, Inc. · Nov 1, 2007
Submission Summary (Full Text)
{0}
K962295
# Summary of Safety and Effectiveness
JUL 26 1996
## Submitted by:
Michael Halpin
Manager of Regulatory and Clinical Affairs
MediSense, Inc.
266 Second Avenue
Waltham MA 02154
## Device Name:
Precision QID™ Blood Glucose Test Strip
## Common Name:
Reagent test strips for Blood Glucose
## Classification:
“Glucose Test System” - Class II per CFR 862.1345
## Predicate Devices:
Precision QID™ Blood Glucose Test Strip - K945887
Accu-Chek Advantage Test Strips - K951887
## Description:
The Precision QID Blood Glucose Test Strip utilizes amperometric biosensor technology to quantitatively measure glucose in whole blood and control solutions. Insertion of a test strip into the sensor, automatically turns the sensor on. A drop of whole blood or control solution is applied to the target area of the test strip and the assay is automatically initiated. A countdown begins and glucose oxidase catalyzes the oxidation of glucose to produce gluconic acid. During the reaction, electrons are transferred by an electrochemical mediator to the electrode surface, generating a current that is measured by the Precision QID Sensor. The size of the current is proportional to the amount of glucose present in the sample, thus giving an accurate reading of glucose concentration after 20 seconds.
Because the Precision QID Blood Glucose Test Strip is an evolutionary offspring of the MediSense Pen 2 / Companion 2 Blood Glucose Test Strip, the Precision QID Blood Glucose Test Strip is fully compatible with the Pen 2/ Companion 2 Test System (K901613), the Satellite G Test System (K891695) which has been renamed to Precision G, The MediSense 2 Pen and Card System (K944195), and the Precision QID Test System (K944195).
## Intended Use:
The Precision QID Blood Glucose Test Strips are intended for in vitro diagnostic use (i.e., for external use only) for the quantitative measurement of glucose in fresh capillary whole blood. For home or professional use with the Precision QID Blood Glucose Sensor. Compatible with the MediSense 2 Card and Pen Blood Glucose Sensors, and the Companion 2 Card and Pen Blood Glucose Sensors.
{1}
The product may also be used by healthcare professionals for quantitative measurement of glucose in venous or arterial whole blood, provided the sample is used within 15 minutes.
## Comparison to Predicate Device:
The proposed Precision QID Blood Glucose Test Strip has technological characteristics equivalent to those of the predicate Precision QID Blood Glucose Test Strip (K945887). The proposed Precision QID Test Strip is identical in form, function, material composition, manufacturing process, and equivalent in intended use to the predicate Precision QID Test Strip. The only difference between the proposed device and the predicate device involves label changes to the Precision QID Test Strip Insert Sheet and User’s Manual. The proposed labeling expands the intended use and would allow healthcare professionals to use arterial whole blood samples. An additional predicate device, the Accu-Chek Advantage Test Strip (K951887), also allows healthcare professionals to use arterial whole blood samples and has the same intended use as the proposed Precision QID Test Strip in that it is intended for use by professionals and people with diabetes for the quantitative determination of glucose in whole blood.
## Performance Studies:
Clinical testing using arterial whole blood was performed at a university medical center by comparison of patient results obtained with the Precision QID Blood Glucose Testing System to results obtained with both a whole blood and a plasma hexokinase reference method. Results for both reference methods are summarized below. In addition, results obtained with the predicate Precision QID Blood Glucose Test Strip using capillary whole blood as compared to a whole blood reference method are included.
| | Precision QID Test Strip Results | | |
| --- | --- | --- | --- |
| Sample Type Used on Precision QID Test Strip | Arterial Whole Blood* | | Capillary Whole Blood** |
| Sample Type Used on Reference Method | Arterial Whole Blood | Arterial Plasma | Capillary Whole Blood |
| Correlation Coefficient (r) | 0.961 | 0.967 | 0.984 |
| Slope (m) | 1.005 | 0.971 | 0.938 |
| Y-intercept, mg/dL | -6.2 | 0.7 | 10.6 |
| N | 320 | 306 | 311 |
| * Results are from pooled data of all test strip lots.
** Results reported in 510(k) submission #K945887 and used for accuracy performance data in label copy. | | | |
{2}
Conclusion:
Results of clinical testing demonstrate that the performance of the Precision QID Blood Glucose Test Strip using arterial whole blood is acceptable and comparable to the performance of the predicate Precision QID Blood Glucose Test Strip using capillary whole blood and that the Precision QID Blood Glucose Testing System is suitable for its intended use.
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.